Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Type of information:
experimental study
Adequacy of study:
key study
Study period:
From January 19th to January 27th, 2022
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2022
Report date:
2022

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
Version / remarks:
Commission Regulation (EC) No. 440/2008, EU-Method B.13/14 adopted May 30th, 2008
Deviations:
no
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Version / remarks:
Adopted June 26th, 2020
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Chemical structure
Reference substance name:
Reaction products of 3,3'-thiodi(propionic acid) and alcohols, C11-14-iso-, C13-rich
EC Number:
823-780-1
Cas Number:
1034820-43-3
Molecular formula:
UVCB substance
IUPAC Name:
Reaction products of 3,3'-thiodi(propionic acid) and alcohols, C11-14-iso-, C13-rich

Method

Species / strain
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102
Additional strain / cell type characteristics:
other: All Salmonella typhimurium strains were obtained from Trinova BioChem GmbH (batch: TA98: 5508D, TA100: 5526D, TA102: 5524D, TA1535: 5504D, TA1537:5530D) and were stored as lyophilizates in the refrigerator at 2 – 8 °C.
Metabolic activation:
with and without
Metabolic activation system:
Type and composition of metabolic activation system:
- S9 was obtained by Trinova Biochem GmbH, Gießen.
- source of S9: livers of male Sprague-Dawley rats which were treated with Phenobarbital/5,6-Benzoflavone.
- composition of S9 mix:
Phosphate buffer 22.5 mL
0.1M NADP-solution 1.0 mL
1M G6P-solution 0.125 mL
Salt solution 0.5 mL
Rat liver S9 1.0 mL
- concentration or volume of S9 mix in the final culture medium: 500 µL
Test concentrations with justification for top dose:
The following nominal test item concentrations were prepared for experiment 1 (Plate incorporation method):
5, 1.5, 0.5, 0.15 and 0.05 µL/plate.

The following nominal test item concentrations were prepared for experiment 2 (Pre-incubation method):
5, 2.5, 1.25, 0.63, 0.31 and 0.16 µL/plate.

The justification for the top dose is that, based on OECD 471, The recommended maximum test concentration for soluble non-cytotoxic substances is 5 mg/plate or 5 μl/plate.
Vehicle / solvent:
In a non-GLP pre-test, the solubility of the test item was tested at in a concentration of 50 mL/L in demineralized (demin.) water, dimethyl sulfoxide (DMSO), acetone and ethanol. The liquid test item is sufficiently soluble in ethanol and acetone. Based on the non-GLP pre-test, ethanol was chosen as vehicle, because the test item was sufficiently soluble, and this solvent does not have any effects on the viability of the bacteria or the number of spontaneous revertants in the tested concentrations.
Dimethylsulfoxide (DMSO) was used for the positive controls 4-Nitro-1,2-phenylene diamine, benzo-a-pyrene and 2-amino-anthracene.
Demineralized water, prepared by LAUS GmbH, from an ion-exchanger, was used for for the positive controls sodium azide and mitomycin C.

Controls
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
sodium azide
benzo(a)pyrene
mitomycin C
other:
Details on test system and experimental conditions:
NUMBER OF REPLICATIONS:
- Number of cultures per concentration: Three plates with (+S9) and three plates without metabolic activation (-S9) were used per bacteria strain and concentration.
- Number of independent experiments: 2 indipendent experiments. The first was performed with the plate incorporation method. The second was performed with the pre-incubation methods.

METHOD OF TREATMENT/ EXPOSURE:
- Cell density at seeding: 10^9 cells/mL
- Plate incorporation method (first experiment): The following materials were gently vortexed in a test tube and poured onto the selective agar plates:

• 100 µL test solution at each dose level, solvent (negative control) or reference mutagen solution (positive control).
• 500 µL S9-mixfor test with metabolic activation or phosphate buffer for test without metabolic activation.
• 100 µL bacteria suspension.
• 2000 µL overlay agar (top agar).
The plates were closed and left to solidify for a few minutes, then inverted and placed in the dark incubator at 37 ± 1 °C.
- Preincubation method (second experiment): The following materials were gently vortexed in a test tube and incubated at 37 ± 1 °C for 20 minutes:

• 100 µL test solution at each dose level, solvent (negative control) or reference mutagen solution (positive control).
• 500 µL S9-mix for test with metabolic activation or phosphate buffer for test without metabolic activation.
• 100 µL bacteria suspension

After the pre-incubation for 20 minutes, 2000 µL top agar was added and the tube was gently slewed. The mixture was poured onto the selective agar plate.
The plates were closed and left to solidify for a few minutes, then inverted and placed in the incubator at 37 ± 1 °C.

TREATMENT AND HARVEST SCHEDULE:
- Preincubation period: 20 minutes at 37 C° only for the second experiment.
- Exposure duration/duration of treatment: 48 h
- Temperature: 37 °C ± 1 °C.

REFERENCES AND VALIDITY:
- Genotype Confirmation: Confirmation of genotype is performed for each batch of lyophilized bacteria by the supplier Trinova BioChem GmbH. The batches used of lyophilized bacteria met the criteria.

- Spontaneous Revertants: The number of spontaneous revertants was determined for each solvent, used in the test by investigating three replicates with and without metabolic activation, incubation for 48 hours at 37 ± 1 °C for each strain.

- Determination of Titre: The titre was determined by dilution of the overnight culture using sodium chloride solution and placing 0.1 mL on maximal-soft agar. It should give a density of 10^9 cells/mL (at the least). Two replicates with and without metabolic activation, incubation for 48 hours at 37 ± 1 °C.

- Sterility Control: Performed analogously to the test item but with solvent only and S9 (without adding bacteria) on top agar. Four replicates, incubation for 48 hours at 37 ± 1 °C.

- Solubility: Plates were checked for precipitation of test item at the end of the incubation by visual inspection.

- Positive Controls: Using diagnostic mutagens. The stock solutions of the substances were diluted to achieve an application volume of 0.1 mL/plate. Three replicates with and without metabolic activation, incubation for 48 hours at 37 ± 1 °C.

EVALUATION:
Five different analysable concentrations were used for the evaluation of the mutagenic potential of the test item.
The colonies were counted visually and the numbers were recorded. A validated spread-sheet software (Microsoft Excel®) was used to calculate mean values and standard deviations of each treatment, negative control and positive control.
The mean values and standard deviations of each threefold determination were calculated as well as the increase factor of revertant induction (mean revertants divided by mean spontaneous revertants) of the test item solutions and the positive controls. Additionally, the absolute number of revertants (mean revertants minus mean spontaneous revertants) is given.
Evaluation criteria:
A result is considered as clearly positive if all the following criteria are fulfilled:
• A concentration-related increase, in revertants
• A clear biological relevant increase in at least one concentration compared to the con-current solvent control
• At least one concentration with an increase above the distribution of historical solvent control data (mean ± 3 SD).

Results and discussion

Test resultsopen allclose all
Species / strain:
S. typhimurium TA 98
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
True negative controls validity:
not examined
Positive controls validity:
valid
Species / strain:
S. typhimurium TA 102
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
True negative controls validity:
not examined
Positive controls validity:
valid
Species / strain:
S. typhimurium TA 100
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
True negative controls validity:
not examined
Positive controls validity:
valid
Species / strain:
S. typhimurium TA 1535
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
True negative controls validity:
not examined
Positive controls validity:
valid
Species / strain:
S. typhimurium TA 1537
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
True negative controls validity:
not examined
Positive controls validity:
valid
Additional information on results:
EXPERIMENT 1 (PLATE INCORPORATION METHOD):
- Confirmation of the Criteria and Validity: All strains met the criterion of at least 10^9 bacteria/mL (correlating to 100 colonies/plate after dilution), and no inconsistencies were found in the sterility control. All determined values for the spontaneous revertants of the vehicle and negative controls were in the normal range of the test laboratory (mean ± 3 standard deviations). All positive controls (diagnostic mutagens) showed mutagenic effects with and without metabolic activation and all were within the historical control data ranges.

- Solubility and Toxicity: In exp. 1, the test item showed no precipitates on the plates in all tested concentrations. The bacterial background lawn was visible and not affected. The number of revertant col-onies was not relevantly reduced. Thus, no signs of toxicity towards the bacteria strains could be observed.

- Mutagenicity: No relevant or concentration-related increase of the number of revertant colonies in the treatments with and without metabolic activation could be observed.

To verify this result, a further experiment (exp. 2) was performed with adapted conditions (pre-incubation method).

EXPERIMENT 2 (PRE-INCUBATION METHOD):
- Confirmation of the Criteria and Validity: All strains met the criterion of at least 10^9 bacteria/mL (correlating to 100 colonies/plate after dilution), and no inconsistencies were found in the sterility control. All determined values for the spontaneous revertants of the vehicle and negative controls were in the normal range of the test laboratory (mean ± 3 standard deviations). All positive controls (diagnostic mutagens) showed mutagenic effects with and without metabolic activation and all were within the historical control data ranges.

- Solubility and Toxicity: In exp. 2, the test item showed no precipitates on the plates in all tested concentrations. The bacterial background lawn was visible and not affected. The number of revertant col-onies was not relevantly reduced. Thus, no signs of toxicity towards the bacteria strains could be observed.

- Mutagenicity: No relevant or concentration-related increase of the number of revertant colonies in the treatments with and without metabolic activation could be observed.

Any other information on results incl. tables














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Μutagenicity Experiment I  - plate incorporation test  - Strain: S. typhimurium TA 98   Μutagenicity Experiment II  - pre-incubation test  - Strain: S. typhimurium TA 98     
 without metabolic activation with metabolic activationConclusion  without metabolic activation with metabolic activationConclusion 
Test item
(μL per plate)
Revertants per platemean ± sdRt/RcRevertants per platemean ± sdRt/Rc Test item
(μL per plate)
Revertants per platemean ± sdRt/RcRevertants per platemean ± sdRt/Rc 
water13131413±0,6-14171816±2,1-validwater10121211± 1,2-14161615± 1,2-valid
EtOH12131413±1-13151916±3,1-EtOH8101110± 1,5-10121613± 3,1-
DMSO15151615±0,6-16161917±1,7-DMSO9101010± 0,6-9131513± 3,1-
514141615±01,21,1514181817±2,31,06not mutagenic5891210± 2,1111121513± 2,11not mutagenic
1,512141714±2,51,0813171816±2,612,5881310± 2,918111612± 40,92
0,513131313±0,0113141815±2,60,941,25710109± 1,70,911111512± 2,30,92
0,1512121312±0,60,9214151615±1,00,940,6310111412± 2,11,211121814± 3,8 
0,0512131915±3,81,1513171716±2,310,319101010± 0,6110161714± 3,81,08
NDP/BaP556560564560±437,3380949590±8,45,29validNDP/BaP512560576549± 33,354,9929610497± 6,18,08 
Μutagenicity Experiment I  - plate incorporation   - Strain: S. typhimurium TA 100           Μutagenicity Experiment II  - pre-incubation test   - Strain: S. typhimurium TA 100           
 without metabolic activation with metabolic activationConclusion  without metabolic activation with metabolic activationConclusion 
Test item
(μL per plate)
Revertants per platemean ± sdRt/RcRevertants per platemean ± sdRt/Rc Test item
(μL per plate)
Revertants per platemean ± sdRt/RcRevertants per platemean ± sdRt/Rc 
water60656965± 4,5-60666865± 4,2-validwater52677063± 9,6-56606259± 3,1-valid
EtOH53596659± 6,5-56566057± 2,3-EtOH48566055± 6,1-53565755± 2,1-
DMSO60667065± 5-64687067± 3,1-DMSO52556959± 9,1-53547059± 9,5-
566707370± 3,51,1954575856± 2,10,98not mutagenic543565752± 7,80,9546545953± 6,60,96not mutagenic
1,556616862± 61,0553565755± 2,10,962,547525852± 5,50,9547506052± 6,80,95
0,556586259± 3,1160616763± 3,81,111,2547495350± 3,10,9150555754± 3,60,98
0,1558586059± 1,2157616461± 3,51,070,6341435045± 4,70,8245475348± 4,20,87
0,0565666866± 1,51,1256606259± 3,11,040,3147495450± 3,60,9150545653± 3,10,96
Na-azide/2-AA496536568533±36,18,21112116812081163± 48,217,36validNa-azide/2-AA400448536461± 697,321176120812401208± 3220,47valid
Μutagenicity Experiment I  - plate incorporation test   - Strain: S. typhimurium TA 102Μutagenicity Experiment II  - pre-incubation test   - Strain: S. typhimurium TA 102
 without metabolic activation with metabolic activationConclusion  without metabolic activation with metabolic activationConclusion 
Test item
(μL per plate)
Revertants per platemean ± sdRt/RcRevertants per platemean ± sdRt/Rc Test item
(μL per plate)
Revertants per platemean ± sdRt/RcRevertants per platemean ± sdRt/Rc 
water148156160155± 6,1-144144148145± 2,3-validwater152156164157± 6,1-148164164159± 9,2-valid
EtOH140152160151± 10,1-136144156145± 10,1-EtOH140156160152± 10,6-156172176168± 10,6-
DMSO144152164153± 10,1-140160160153± 11,5-DMSO140152168153± 14-148156164156± 8-
5148156160155± 6,11.03148152164155± 8,31.07not mutagenic5144148164152± 10,61136144160147± 12,20,88not mutagenic
1,5144148160151± 8,31.00140148152147± 6,31.012,5144148156149± 6,10,98160164164163± 2,30,97
0,5136136140137± 2,30.91132136144137± 6,10.941,25144152164153± 10,11,01148160164157± 8,30,93
0,15132144156144± 120.95132132136133± 2,30.920,63144156164155± 10,11,02160168172167± 6,10,99
0,05132140160144± 14,4    0.95128136156140± 14,40.970,31144148160151± 8,3    0,99164172172169± 4,61,01
MMC/2-AA480484528497±26,63,34472484500485±14,03,17validMMC/2-AA808872904861±48,95,481016104811201061±53,36,8valid
Μutagenicity Experiment I  - plate incorporation test   - Strain: S. typhimurium TA 1535Μutagenicity Experiment II  - pre-incubation test   - Strain: S. typhimurium TA 1535
 without metabolic activation with metabolic activationConclusion  without metabolic activation with metabolic activationConclusion 
Test item
(μL per plate)
Revertants per platemean ± sdRt/RcRevertants per platemean ± sdRt/Rc Test item
(μL per plate)
Revertants per platemean ± sdRt/RcRevertants per platemean ± sdRt/Rc 
water7888± 0,6-88109± 1,2-validwater7998± 1,2-6676± 0,6-valid
EtOH7888± 0,6-991110± 1,2-EtOH5666± 0,6-8888± 0,00-
DMSO7777± 0,0-7898± 1,0-DMSO6787± 1-6797± 1,5-
57898± 1,017898± 1,00,8not mutagenic55686± 1,516777± 0,60,88not mutagenic
1,589109± 11,1379119± 20,92,55676± 1167108± 2,11
0,58898± 0,617787± 0,60,71,257888± 0,61,337898± 11
0,1589109± 11,13991110± 1,210,636787± 11,177798± 1,21
0,058999± 0,61,1389119± 1,50,90,317898± 11,336676± 0,60,75
Na-azide/2-AA184152190175±20,421,8888111114104± 14,213validNa-azide/2-AA132136158142±14,017,75120148160143± 20,520,43valid
Μutagenicity Experiment I  - plate incorporation test   - Strain: S. typhimurium TA 1537Μutagenicity Experiment II  - pre-incubation test   - Strain: S. typhimurium TA 1537
 without metabolic activation with metabolic activationConclusion  without metabolic activation with metabolic activationConclusion 
Test item
(μL per plate)
Revertants per platemean ± sdRt/RcRevertants per platemean ± sdRt/Rc Test item
(μL per plate)
Revertants per platemean ± sdRt/RcRevertants per platemean ± sdRt/Rc 
water3464± 1,5-4454± 0,6-validwater3354± 1,2-5565± 0,6-valid
EtOH3354± 1,2-3565± 1,5-EtOH2343± 1-3464± 1,5-
DMSO3575± 2-4565± 1-DMSO4555± 0,6-3364± 1,7-
54565± 11,253554± 1,20,8not mutagenic53333± 0,0013454± 11not mutagenic
1,53464± 1,513485± 2,612,52343± 114565± 11,25
0,53485± 2,61,254444± 00,81,253333± 0,0012343± 10,75
0,153475± 2,11,255666± 0,61,20,633333± 0,0014454± 0,61
0,053385± 2,91,253675± 2,110,313333± 0,0013444± 0,61
NDP/2-AA52616860±81281899187±5,317,4validNDP/2-AA65738374±914,850546155±5,613,75valid

Applicant's summary and conclusion

Conclusions:
Based on the results of this study it is concluded that Di(tridecyl) 3,3'-thiodipropionate is not mutagenic in the Salmonella typhimurium strains TA98, TA100, TA102, TA1535 and TA1537 in the presence and absence of metabolic activation under the experimental conditions of this study.
Executive summary:

This study was performed in order to evaluate the mutagenic potential of Di(tridecyl) 3,3'-thiodipropionate in the Bacterial Reverse Mutation Test using five strains of Salmonella typhimurium (TA98, TA100, TA102, TA1535 and TA1537) based on the most recent Guidelines OECD 471 (2020) and EU Method B.13/14 (2008). The test was performed in two valid experiments at a cell density of 10^9 cells/mL in the presence and absence of metabolic activation, with +S9 standing for the presence of a metabolic activation, and -S9 standing for absence of metabolic activation.


In the first experiment, the test item (dissolved in ethanol) was tested up to concentrations of 5 µL/plate in the absence and presence of S9 mix in the strains TA98, TA100, TA102, TA1535 and TA1537 using the plate incorporation method. The test item showed no precipitates on the plates at any of the concentrations and no signs of cytotoxicity could be observed in the presence and the absence of metabolic activation. The results of this experiment showed that none of the tested concentrations induced a relevant or concentration-related increase in the number of revertants in all tested strains, in the presence and the absence of metabolic activation. Therefore, a further experiment with adapted conditions (pre-incubation method) was performed (exp. 2).


Based on the results of the first experiment, the test item was tested up to concentrations of 5 µL/plate in the presence and absence of S9 mix in all bacteria strains using the pre-incubation method. The test item showed no precipitates on the plates at any of the concentrations and no signs of cytotoxicity could be observed in the presence and the absence of metabolic activation.


The results of this experiment showed that none of the tested concentrations induced a relevant or concentration-related increase in the number of revertants in all tested strains, in the presence and the absence of metabolic activation.